92 results
6-K
EX-99.1
GNFT
Genfit
25 Apr 24
Current report (foreign)
4:10pm
of developing innovative, effective and safe therapeutic solutions for patients suffering from rare and severe liver diseases with a high unmet medical
6-K
EX-99.1
GNFT
Genfit
7 Dec 23
Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC
6:37am
of Ipsen’s patents and other protections for innovative medicines; and the exposure to litigation, including patent litigation, and/or regulatory actions
6-K
EX-99.1
bvusclzfjo2
16 Nov 23
GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
4:10pm
6-K
EX-99.1
s3zj9tlh8p8 uq7lj
13 Nov 23
Current report (foreign)
4:30pm
6-K
EX-99.1
5wx70fkxnp
6 Nov 23
GENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023
7:00am
6-K
EX-99.1
jb2dsp
20 Sep 23
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
4:51pm
6-K
EX-99.1
r8f635oj
20 Sep 23
Current report (foreign)
4:44pm
6-K
EX-99.1
nbh1d q79hc7w8
5 Sep 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm
6-K
EX-99.1
zpi9nw
10 Aug 23
GENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology Communications
4:10pm
6-K
EX-99.1
40b20f
12 Jul 23
Current report (foreign)
12:00am
6-K
EX-99.1
5tajqwq
30 Jun 23
Current report (foreign)
6:00am
6-K
EX-99.1
hvwvxu4gcl1ty
7 Jun 23
GENFIT Announces New Data at the European Association for the Study of the Liver (EASL) Congress 2023
4:10pm
6-K
EX-99.1
yk457lt2kjo0v4h
31 May 23
GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset
4:15pm
6-K
EX-99.1
58ibp
24 May 23
Current report (foreign)
3:00pm
6-K
EX-99.1
pv515l4wct1 5tq9in
23 May 23
GENFIT Announces Publication of the Development and Validation of NIS2+™ in the Journal of Hepatology
4:10pm
6-K
EX-99.1
ynoex6u fn
11 May 23
GENFIT Reports First Quarter 2023 Financial Information1
4:10pm
6-K
EX-99.1
r09g3alrxot
9 May 23
GENFIT Presents Phase 1 Clinical Data Evaluating NTZ at Digestive Disease Week® as part of its ACLF Program
4:10pm